The Multiple Sclerosis Genomic Map: Role of peripheral immune cells and resident microglia in susceptibility
NA Patsopoulos(Broad Institute), Efthimios Dardiotis(University of Thessaly), An Goris(University of Cambridge), Maria Cimpean, Sergio E. Baranzini(University of California, San Francisco), Philip Winn(Columbia University Irving Medical Center), Henrik Ullum(Statens Serum Institut), Achim Berthele, Cristin McCabe, Benjamin Knier(Evangelisches Diakoniekrankenhaus), Brendan T Keenan(University of Pennsylvania), Bernhard Hemmer(Munich Cluster for Systems Neurology), Sandra Vukusik(Inserm), Aaron Brandes(Broad Institute), Mark Mühlau(Technical University of Munich), A K Robbins(Columbia University Irving Medical Center), Ioannis S. Vlachos(Broad Institute), Verena Grummel(Tampere University), I. Rebeix(Inserm), Felix Luessi, Bertrand Fontaine(Institut du Cerveau), Jeri Replogle(Columbia University Irving Medical Center), Thomas Korn(TUM Klinikum), Christiane Graetz(Johannes Gutenberg University Mainz), Tune H. Pers(Novo Nordisk Foundation), Janna Saarela(University of Helsinki), Christiane Gasperi, Tojo James, Frauke Zipp(Johannes Gutenberg University Mainz), Vincent Damotte, Helle Bach Søndergaard, Adam Santaniello(University of California, San Francisco), IP Panteliadis(Broad Institute), Onigiusz Zarzycki, Parisa Shoostari, Chris Cotsapas(Yale University), Bénédicte Dubois(University of California, San Francisco), CM Lill(Johannes Gutenberg University Mainz), Viola Biberacher(TUM Klinikum), Per Soelberg Sorensen, Charles C. White(Boston University), Lise Wegner Thoerner(University of Copenhagen), AH Beecham(University of Miami), Dorothea Buck, Léna Guillot Noel(Inserm), Mark Lathrop(McGill Genome Centre), Finn Sellebjerg(Kaiser Permanente), G Wong(Brigham and Women's Hospital), Muna Hoshi(TUM Klinikum)
Cited by 116
Related Papers
New insights into the genetic etiology of Alzheimer’s disease and related dementias
|Nature Genetics|2022|2.5k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
|New England Journal of Medicine|2016|1.9k
Multiple sclerosis
|The Lancet|2018|1.8k
DIANA-miRPath v3.0: deciphering microRNA function with experimental support
|Nucleic Acids Research|2015|1.8k